Keywords: pfizer, debuts, revatio, pah, uk, global, pharmaceutical

Pfizer debuts Revatio for PAH in the UK

Article | 13 March 2006

Print This

Global pharmaceutical giant Pfizer says it has launched its drug Revatio (sildenafil citrate) as a new treatment for pulmonary arterial ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in